| 李 溪,俞超芹.靶向肿瘤相关巨噬细胞治疗卵巢癌的研究进展[J].中国肿瘤,2019,28(2):137-142. |
| 靶向肿瘤相关巨噬细胞治疗卵巢癌的研究进展 |
| Advances in Immunotherapy Targeting Tumor-associated Macrophages for Ovarian Cancer |
| 投稿时间：2018-09-21 |
| DOI：10.11735/j.issn.1004-0242.2019.02.A012 |
|
 |
| 中文关键词: 肿瘤相关巨噬细胞 卵巢肿瘤 靶向治疗 |
| 英文关键词:tumor-associated macrophages ovarian neoplasms targeted therapy |
| 基金项目:国家自然科学基金青年项目（81603651） |
|
| 摘要点击次数: 1841 |
| 全文下载次数: 402 |
| 中文摘要: |
| 摘 要：卵巢癌是女性生殖系统中致死率最高的恶性肿瘤，严重威胁着女性的健康。近年来越来越多的研究关注到卵巢癌与其所处免疫微环境之间的相互作用。肿瘤相关巨噬细胞是肿瘤免疫微环境中数量最多的免疫细胞，贯穿了卵巢癌发生、发展的各个阶段。多项临床研究已经证实肿瘤相关巨噬细胞的数量及极化状态与卵巢癌患者的预后密切相关。本文概述了直接靶向肿瘤相关巨噬细胞的临床研究进展，以期对卵巢癌的临床治疗提供参考。 |
| 英文摘要: |
| Abstract：Ovarian cancer has the highest mortality rate among gynecologic malignancies，which is a serious threat to women’s health. In recent years，more and more studies have shown the interaction between the ovarian cancer and its immune microenvironment. Tumor-associated macrophages (TAMs) are the most numerous immune cells in the tumor microenvironment，it plays an important role in the development of ovarian cancer. This article reviews the research progress of clinical strategies that directly targeting TAMs，to provide reference for the clinical treatment of ovarian cancer. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |